We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WIX icon
551
WIX.com
WIX
$2.45B
$202K 0.1%
+1,946
New +$235K
ATAT icon
552
Atour Lifestyle Holdings
ATAT
$4.77B
$202K 0.1%
5,130
-5,593
-52% -$219K
SEI
553
Solaris Energy Infrastructure
SEI
$2.9B
$201K 0.1%
4,376
-6,672
-60% -$323K
GM icon
554
General Motors
GM
$81.7B
$201K 0.1%
+2,471
New +$174K
TBLA icon
555
Taboola.com
TBLA
$1.37B
$201K 0.1%
43,584
-20,804
-32% -$78.3K
HGTY icon
556
Hagerty
HGTY
$1.24B
$201K 0.1%
+14,937
New +$186K
ALNY icon
557
Alnylam Pharmaceuticals
ALNY
$38.5B
$200K 0.1%
+504
New +$223K
HR icon
558
Healthcare Realty
HR
$7.58B
$200K 0.1%
+11,818
New +$210K
CNM icon
559
Core & Main
CNM
$8.23B
$200K 0.1%
+3,851
New +$198K
TEM
560
Tempus AI
TEM
$7.72B
$200K 0.1%
+3,389
New +$265K
SVM
561
Silvercorp Metals
SVM
$2.08B
$200K 0.1%
+23,925
New +$174K
EGAN icon
562
eGain
EGAN
$190M
$199K 0.1%
+19,375
New +$232K
WNC icon
563
Wabash National
WNC
$541M
$198K 0.1%
+22,924
New +$200K
TALO icon
564
Talos Energy
TALO
$2.28B
$198K 0.1%
17,979
-4,571
-20% -$47.8K
VNET
565
VNET Group
VNET
$1.92B
$197K 0.1%
+23,257
New +$216K
UGP icon
566
Ultrapar
UGP
$6.74B
$196K 0.1%
51,880
+23,498
+83% +$92.9K
FSM icon
567
Fortuna Silver Mines
FSM
$2.55B
$195K 0.1%
19,895
-5,412
-21% -$48.7K
CRNC icon
568
Cerence
CRNC
$368M
$194K 0.1%
+18,186
New +$200K
BDN
569
Brandywine Realty Trust
BDN
$521M
$194K 0.1%
66,525
-32,830
-33% -$112K
FPI
570
Farmland Partners
FPI
$417M
$194K 0.1%
+20,034
New +$201K
LIND icon
571
Lindblad Expeditions
LIND
$1.95B
$194K 0.1%
+13,431
New +$169K
CGAU
572
Centerra Gold
CGAU
$3.19B
$193K 0.1%
+13,410
New +$168K
SBGI icon
573
Sinclair Inc
SBGI
$1.02B
$192K 0.1%
+12,562
New +$187K
VIV icon
574
Telefônica Brasil
VIV
$21B
$192K 0.1%
16,196
-2,590
-14% -$32.1K
FLYW icon
575
Flywire
FLYW
$2.04B
$192K 0.1%
+13,533
New +$185K
21 22
23
24 25

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.